- About UsOur Story, Our Team & Support Information
- What We DoAdvocacy to Achieve the End of AIDS
- Advance HIV/SRH Integration
- Advocate for Access to High-Impact Prevention
- Improve Research Conduct
- Product Innovation & Availability
- Promote Effective HIV Prevention Policy
- Strengthen Global Advocacy Networks
- Track and Translate the Field
- Our FocusInterventions to End the Epidemic
- ResourcesPublications, Infographics, Events & More
- MediaInformation & Resources for the Press
- Our BlogPrevention News & Perspective
November 4, 2021
General
On Thursday, November 4th, award-winning journalist Stephanie Nolen joined AVAC to discuss the findings and backstory of her recent New York Times investigation,"Here’s Why Developing Countries Can Make mRNA COVID Vaccines." During the webinar, Stephanie, AVAC and partners explored where we are in the fight to bring COVID mRNA vaccine manufacturing to the places where doses are needed most, in countries where vaccine access has been grievously stalled. We also talked through her report and discussed the parallels with HIV.
Speakers:
- Mitchell Warren, AVAC
- Stephanie Nolen, New York Times
- Zain Rizvi, Public Citizen
Watch the recording and download the transcript.